Related Articles
Novel strategies in the treatment of castration-resistant prostate cancer (Review)
Targeting MRP4 expression by anti-androgen treatment reverses MRP4-mediated docetaxel resistance in castration-resistant prostate cancer
Partial response of liver metastases treated with abiraterone in castration-resistant prostate cancer: A case report
MicroRNA‑149 inhibits cancer cell malignant phenotype by regulating Akt1 in C4‑2 CRPC cell line
Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration‑resistant prostate cancer